10 October 2023
Today Oxford University has launched a new global collaboration backed by £8 million funding from UK Research and Innovation (UKRI). The project will be spearheaded by Professor Teresa Lambe, Professor of Vaccinology and Immunology and Calleva Head of Vaccine Immunology in the Department of Paediatrics and Professor Paul Klenerman, Sidney Truelove Professor of Gastroenterology and Director of the Translational Gastroenterology Unit at NDM, both of whom are Principal Investigators at NDM’s Pandemic Sciences Institute.
6 July 2023
Updated data from the ongoing OCTAVE trial, a collaboration between the Universities of Glasgow, Birmingham and Oxford, show for the first time that most clinically at-risk patients with a range of immunocompromised or immunosuppressed conditions in the UK were protected from severe COVID by the vaccination programme.
7 June 2023
Within weeks of the pandemic starting, the Nuffield Department of Medicine (NDM) began antibody testing as part of the UK’s ONS COVID-19 Infection Survey. The platform successfully tested millions of blood samples over three years, providing invaluable information on how vaccinations and previous infections affect the chance of getting COVID-19 again.
17 April 2023
Thousands of immunosuppressed people, including patients at Oxford University Hospitals (OUH), have the chance to take part in a landmark new study investigating which people are still at the greatest risk of COVID-19 infection after vaccination.
3 April 2023
Kevin Chau, a PhD student on our National PhD Training Programme in AMR Research, has contributed to the pandemic response as part of the Modernising Medical Microbiology team at John Radcliffe Hospital in Oxford. In a new blog post, he describes the experience.
5 January 2023
We are delighted to announce that three researchers have been awarded the Associate Professor title, in recognition of their research achievements, contribution to teaching, and contribution to the general work of the Nuffield Department of Medicine.
3 May 2022
A new National Institute for Health and Care Research (NIHR) BioResource aimed at investigating inflammatory bowel disease (IBD) in children has opened, with the NIHR Oxford BRC playing a key role.
21 September 2021
The fast spread of the highly infectious Delta variant underscores the need for faster identification of COVID-19 mutations. Uniting governments and medical communities in this challenge, the University of Oxford and Oracle’s Global Pathogen Analysis System (GPAS) is now being used by organizations on nearly every continent. Institutions using the platform include: the University of Montreal Hospital Centre Research Centre, the Institute of Public Health Research of Chile, the Oxford University Clinical Research Unit in Vietnam, the Institute of Clinical Pathology and Medical Research – New South Wales Pathology, and Oxford Nanopore Technologies. GPAS is also now part of the Public Health England New Variant Assessment Platform.
20 September 2021
‘Finding Our Way – An NHS Tribute Garden’ is a celebration of the incredible efforts of the thousands of people who fought – and are still fighting - the COVID-19 pandemic on our behalf. Designed by Naomi Ferrett-Cohen and presented by Oxford University Hospitals NHS Foundation Trust and Oxford University.
31 August 2021
Writing in the journal Nature Immunology, they detail an investigation into one of the key features of adenovirus vaccines – their ability to generate strong and sustained populations of the ‘killer’ T-cell element of the immune system.
31 August 2021
The University has signed an agreement with Sensyne Health to conduct a multi-omics drug discovery research project in asthma. The project will be led by Dr Timothy Hinks at his team at the Nuffield Department of Medicine’s Respiratory Medicine Unit.
24 August 2021
A national study has found that a significant proportion of clinically at-risk patients with certain immunocompromised or immunosuppressed conditions, mount a low, or undetectable, immune response after two doses of the same COVID-19 vaccine.
20 October 2020
Two vital research programmes taking place at the University of Oxford may hold the key to understanding the immunity of recovered Covid-19 patients. The data will also be used by Professor Sarah Walker at the University of Oxford who is working with the Office for National Statistics on the COVID-19 Infection Survey.
25 September 2020
Scientists from the University of Oxford’s Nuffield Department of Medicine have today published their evaluation of LamPORE, a novel diagnostic platform for detecting SARS-CoV-2 RNA. It combines loop-mediated isothermal amplification with nanopore sequencing. This technology has the potential to analyse thousands of samples per day on a single instrument.
3 February 2020
Many congratulations to Prof Anne Goriely and Prof Alison Simmons, who have both been awarded Wellcome Trust Investigator Awards.